TNF and neoplasm: Our observation that TNF-α is highest in metastatic (Stage IV) disease and correlates with markers like CA19-9 fits this paradigm: as the tumor burden increases, TNF-α levels rise, potentially aiding processes like tumor spread and immune evasion.